Skip to main content

. 1970 May;46(535):330–331. doi: 10.1136/pgmj.46.535.330

Death from paralytic ileus following vincristine therapy.

P J Toghill, J D Burke

PMCID: PMC2467012 PMID: 5270680

330

Images in this article

Fig. 1
on p.330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BOHANNON R. A., MILLER D. G., DIAMOND H. D. Vincristine in the treatment of lymphomas and leukemias. Cancer Res. 1963 May;23:613–621. [PubMed] [Google Scholar]
COSTA G., HRESHCHYSHYN M. M., HOLLAND J. F. Initial clinical studies with vincristine. Cancer Chemother Rep. 1962 Nov;24:39–44. [PubMed] [Google Scholar]
GUBISCH N. J., NORENA D., PERLIA C. P., TAYLOR S. G., 3rd EXPERIENCE WITH VINCRISTINE IN SOLID TUMORS. Cancer Chemother Rep. 1963 Oct;32:19–22. [PubMed] [Google Scholar]
MARTIN J., COMPSTON N. VINCRISTINE SULPHATE IN THE TREATMENT OF LYMPHOMA AND LEUKAEMIA. Lancet. 1963 Nov 23;2(7317):1080–1083. doi: 10.1016/s0140-6736(63)92855-1. [DOI] [PubMed] [Google Scholar]
SHAW R. K., BRUNER J. A. CLINICAL EVALUATION OF VINCRISTINE (NSC-67574). Cancer Chemother Rep. 1964 Nov;42:45–48. [PubMed] [Google Scholar]

ACTIONS

RESOURCES